乙型病毒性肝炎不同状态合并2型糖尿病临床特征

来源期刊：广州医药 | 7-11 发布时间：2022-04-12 收稿时间：2025/11/13 18:23:38 阅读量：28

作者：: 彭喜春,

孙艳,

关键词：: 乙型病毒性肝炎感染状态 2型糖尿病; viral hepatitis B infection status type 2 diabetes

DOI：: 10.3969/j.issn.1000-8535.2022.02.002

收稿时间：: 2021-05-07
修订日期：
接收日期：
引用总数：: 1

目的探究乙型病毒性肝炎不同状态合并2型糖尿病患者的临床特点。方法对62例乙型肝炎病毒携带合并2型糖尿病(组1)、129例乙型病毒性肝炎合并2型糖尿病(组2)和83例乙型病毒性肝炎肝硬化合并2型糖尿病(组3)患者的临床资料进行回顾性分析。结果各组间在性别和年龄上差异有统计学意义(χ²=11.133、P=0.004,F=7.640、P=0.001)。3组研究对象糖化血红蛋白(HbA1c)、总胆固醇(Tch)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血清白蛋白(ALB)、总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL)和总胆汁酸(TBA)水平差异有统计学意义(F=4.028、P=0.019,F=4.140、P=0.017,F=3.172、P=0.044,F=6.701、P=0.002,F=53.156、P<0.001,F=4.920、P=0.008,F=4.173、P=0.017,F=7.181、P=0.001,F=9.170、P<0.001)。进一步两两比较,肝炎肝硬化组HbA1c、Tch 、LDL-C、ALB水平降低,但TBIL、IBIL、TBA增高,分别与另2组比较差异有统计学意义(P<0.05);组2空腹血糖(FBG)、HDL-C水平最高,前者高于组1,后者高于组3。各组糖尿病并发症居前三的都是周围神经病变、糖尿病肾病和糖尿病视网膜病变。结论乙型病毒性肝炎合并2型糖尿病时其不同状态间具有不同的疾病特点,主要体现在携带状态Tch、TG、LDL-C高水平,肝炎状态FBG高水平,肝炎肝硬化状态HbAlc、ALB低水平但胆红素、胆汁酸水平高,在糖尿病并发症方面均以周围神经病变、糖尿病肾病和糖尿病视网膜病变为主。

Objective To study the clinical feature of different viral hepatitis B status with type 2 diabetes. Methods A retrospective analysis was carried out on 62 hepatitis B virus carriers with type 2 diabetes (group 1),129 viral hepatitis B patients with type 2 diabetes (group 2) and 83 viral hepatitis B cirrhosis patients with type 2 diabetes (group 3). Results The differences in gender and age among the three groups were significantly different (χ²=11.133, P=0.004 and F=7.640,P=0.001). The levels of HbA1c, total cholesterol (Tch), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), serum albumin (ALB), total bilirubin(TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL)and total bile acid (TBA)in three groups were significantly different (F=4.028, P=0.019.F=4.140, P=0.017.F=3.172, P=0.044.F=6.701, P=0.002.F=53.156, P<0.001.F=4.920, P=0.008.F=4.173, P=0.017.F=7.181, P=0.001.F=9.170, P<0.001). In further pairwise comparison, the levels of HbA1c, Tch, LDL-C and ALB of group 3 decreased significantly compared with other two groups, but the levels of TBIL, IBIL and TBA increased, with significant differences.The levels of fasting blood glucose(FBG) and HDL-C in group 2 were the highest,and the FBG was significantly higher than that in group 1, while the HDL-C was significantly higher than that in group 3.In the three groups, the top three diabetic complications were peripheral neuropathy, diabetic nephropathy and diabetic retinopathy. Conclusion Different statuses of viral hepatitis B with type 2 diabetes had different disease characteristics, mainly reflected in the high levels of Tch, TG and LDL-C in the hepatitis B virus carriers, high FBG level in the viral hepatitis B patients, low levels of HbAlc and ALB but high levels of bilirubin and bile acid in the cirrhosis patients.Peripheral neuropathy, diabetic nephropathy and diabetic retinopathy were the main complications of diabetes.

1、冯杏风,麦镇流,黄宝明,等.胰岛素联合羟苯磺酸钙治疗早期糖尿病视网膜病变的临床分析[J].现代医院,2020,20(11):1690-1693.

2、傅健钊,刘勇波,陈燕如,等.血清同型半胱氨酸、β₂微球蛋白及视黄醇结合蛋白联合检测对2型糖尿病早期肾损害的诊断价值[J].现代医院,2020,20(11):1713-1716.

3、中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版) [J].中国糖尿病杂志, 2014, 22(8):2-42.

4、努尔比亚·西里甫,伊尔番·阿不都艾尼.探究2型糖尿病患者慢性并发症的临床特点及相关因素[J].中国保健营养, 2019, 29 (27):144.

5、贾绍静,米光丽,郑栋莲,等.宁夏2型糖尿病住院患者慢性并发症的现状调查及影响因素分析[J].实用医学杂志, 2018, 34(3):472-476.

6、贺小宁,张雅雯,阮贞,等.中国2型糖尿病患者慢性并发症患病率与次均医疗费用研究[J].中华内分泌代谢杂志, 2019, 35(3):200-205.

7、廖二元.内分泌学[M].北京:人民卫生出版社, 2001:1574.

8、杜映红,马杜娟.乙型肝炎肝硬化合并糖尿病患者糖脂代谢分析[J].广州医学院学报, 2013, 41(1):23-25.23.

9、柯飒,邓媛媛,章鑫煦,等.慢性乙型肝炎患者糖代谢异常的研究进展[J].中国感染控制杂志, 2019, 18(7):696-700.

10、林学,陈川英,陈芳,等.乙肝肝硬化合并糖尿病临床特点及预后分析[J].当代医学, 2019, 25(10):17-19.

11、何刘,张照如.2型糖尿病对乙型病毒性肝炎肝硬化患者肝功能的影响及其相关性分析[J].安徽医药, 2017, 21(11):2016-2018.

12、 KIM E S, LEE S W, MO E Y, et al. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patientswith type 2 diabetes [J].Endocrine, 2015, 50(2): 405-412.

13、王保法, 傅莉萍, 洪郁芝.血清胆红素对2型糖尿病慢性并发症的预测作用[J].浙江临床医学, 2020, 22(7):1028-1029, 1033.

14、杨艳霞,苏青.胆红素与糖尿病慢性并发症相关性研究[J].中华内分泌代谢杂志, 2016, 32 (5):426-428.

15、陈芳,涂相林,陈川英,等.慢性乙型肝炎患者糖耐量减低的相关性分析及危险因素的筛选[J].中国现代医学杂志, 2014, 24(22):66-70.

16、刘纯,明洁,徐少勇.肝源性糖尿病的诊断和治疗[J].医学综述, 2018, 24 (8):1580-1585.

17、鲁明月,李静.肝源性糖尿病的发病机制及诊疗进展[J].锦州医科大学学报, 2018, 39(6):92-96.

18、惠威,徐斌,郭新会.乙型肝炎病毒相关的肝源性糖尿病糖代谢异常的临床分析[J].临床肝胆病杂志, 2012, 28(7):538-541.

19、刘娜,武琼,徐光华.慢性HBV携带状态自然转归的研究[J].肝脏, 2016, 21(9):755-758.

20、林学,陈川英,陈芳,等.乙肝肝硬化合并糖尿病临床特点及预后分析[J].当代医学, 2019, 25(10): 17-19.

21、赵长青, 顾宏图,邢枫,等.乙型肝炎肝硬化合并糖尿病的临床特点[J].临床肝胆病杂志, 2012, 28(6): 450-455.

22、胡虹英,刘颖,杨金奎.2型糖尿病合并乙型肝炎病毒携带患者的临床分析[J].首都医科大学学报, 2011, 32(5): 602-604.

23、中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].中华实验和临床感染病杂志(电子版), 2019, 13(6):441-466.

24、中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].实用肝脏病杂志, 2016, 19(3):V-XVI.